It is known that the pro-inflammatory transcription factor NF-κB promotes and stimulates the expression of anti-apoptotic biomarkers (tumor-promoting proteins) such as survivin, Bcl-2, and Bcl-xL [54,55,56,57,58,59,60,61]. Here, BCL2L1 is linked to neoplasm.